JBCHEPHARM at 20x FY23 EPS is a much safer and a better buy than a conventional FMCG Player like HINDUNILVR with no significant reinvestment moat and single digit earnings growth.

The difference here is that JB can still reinvest bulk of its cash flows at a similar/higher ROIIC.

More from Saket Reddy

You May Also Like

#24hrstartup recap and analysis

What a weekend celebrating makers looks like.

A thread

👇Read on

Let's start with a crazy view of what @ProductHunt looked like on Sunday

Download image and upload

A top 7 with:
https://t.co/6gBjO6jXtB @Booligoosh
https://t.co/fwfKbQha57 @stephsmithio
https://t.co/LsSRNV9Jrf @anthilemoon
https://t.co/Fts7T8Un5M @J_Tabansi
Spotify Ctrl @shahroozme
https://t.co/37EoJAXEeG @kossnocorp
https://t.co/fMawYGlnro

If you want some top picks, see @deadcoder0904's thread,

We were going to have a go at doing this, but he nailed it.

It also comes with voting links 🖐so go do your


Over the following days the 24hr startup crew had more than their fair share of launches

Lots of variety: web, bots, extensions and even native apps

eg. @jordibruin with
1. Project 1742 (EcoHealth/DTRA)
Risks of bat-borne zoonotic diseases in Western Asia

Duration: 24/10/2018-23 /10/2019

Funding: $71,500
@dgaytandzhieva
https://t.co/680CdD8uug


2. Bat Virus Database
Access to the database is limited only to those scientists participating in our ‘Bats and Coronaviruses’ project
Our intention is to eventually open up this database to the larger scientific community
https://t.co/mPn7b9HM48


3. EcoHealth Alliance & DTRA Asking for Trouble
One Health research project focused on characterizing bat diversity, bat coronavirus diversity and the risk of bat-borne zoonotic disease emergence in the region.
https://t.co/u6aUeWBGEN


4. Phelps, Olival, Epstein, Karesh - EcoHealth/DTRA


5, Methods and Expected Outcomes
(Unexpected Outcome = New Coronavirus Pandemic)